Development of monoclonal gammopathy in 12 patients receiving efalizumab treatment for chronic plaque psoriasis

J Am Acad Dermatol. 2010 Oct;63(4):e84-7. doi: 10.1016/j.jaad.2009.12.040.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Paraproteinemias / chemically induced*
  • Paraproteinemias / pathology
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Risk Assessment
  • Sampling Studies
  • Severity of Illness Index

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • efalizumab